429 related articles for article (PubMed ID: 34493193)
1. Anti-inflammatory Effects of Mesenchymal Stem Cells and their Secretomes in Pneumonia.
Hezam K; Mo R; Wang C; Liu Y; Li Z
Curr Pharm Biotechnol; 2022; 23(9):1153-1167. PubMed ID: 34493193
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities.
Moradinasab S; Pourbagheri-Sigaroodi A; Zafari P; Ghaffari SH; Bashash D
Int Immunopharmacol; 2021 Aug; 97():107694. PubMed ID: 33932694
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cell-derived extracellular vesicles modulate the therapeutic efficacy of mesenchymal stem cells through IDH2/TET pathway in ARDS.
Wu X; Tang Y; Lu X; Liu Y; Liu X; Sun Q; Wang L; Huang W; Liu A; Liu L; Chao J; Zhang X; Qiu H
Cell Commun Signal; 2024 May; 22(1):293. PubMed ID: 38802896
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.
Gorman E; Millar J; McAuley D; O'Kane C
Expert Rev Respir Med; 2021 Mar; 15(3):301-324. PubMed ID: 33172313
[No Abstract] [Full Text] [Related]
5. Therapeutic Use of Extracellular Vesicles for Acute and Chronic Lung Disease.
Worthington EN; Hagood JS
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230828
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease.
Liu A; Zhang X; He H; Zhou L; Naito Y; Sugita S; Lee JW
Expert Opin Biol Ther; 2020 Feb; 20(2):125-140. PubMed ID: 31701782
[No Abstract] [Full Text] [Related]
8. Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial.
Zarrabi M; Shahrbaf MA; Nouri M; Shekari F; Hosseini SE; Hashemian SR; Aliannejad R; Jamaati H; Khavandgar N; Alemi H; Madani H; Nazari A; Amini A; Hassani SN; Abbasi F; Jarooghi N; Fallah N; Taghiyar L; Ganjibakhsh M; Hajizadeh-Saffar E; Vosough M; Baharvand H
Stem Cell Res Ther; 2023 Jun; 14(1):169. PubMed ID: 37365605
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics.
Qin H; Zhao A
Protein Cell; 2020 Oct; 11(10):707-722. PubMed ID: 32519302
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives.
Fernández-Francos S; Eiro N; González-Galiano N; Vizoso FJ
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360616
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of TGFβ1 in murine mesenchymal stem cells improves lung inflammation by impacting the Th17/Treg balance in LPS-induced ARDS mice.
Chen J; Zhang X; Xie J; Xue M; Liu L; Yang Y; Qiu H
Stem Cell Res Ther; 2020 Jul; 11(1):311. PubMed ID: 32698911
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stem Cells in the Treatment of COVID-19, a Promising Future.
Beghini DG; Horita SI; Henriques-Pons A
Cells; 2021 Sep; 10(10):. PubMed ID: 34685567
[TBL] [Abstract][Full Text] [Related]
13. Investigational Use of Mesenchymal Stem/Stromal Cells and Their Secretome as Add-On Therapy in Severe Respiratory Virus Infections: Challenges and Perspectives.
Mattoli S; Schmidt M
Adv Ther; 2023 Jun; 40(6):2626-2692. PubMed ID: 37069355
[TBL] [Abstract][Full Text] [Related]
14. Lung inflammatory environments differentially alter mesenchymal stromal cell behavior.
Abreu SC; Rolandsson Enes S; Dearborn J; Goodwin M; Coffey A; Borg ZD; Dos Santos CC; Wargo MJ; Cruz FF; Loi R; DeSarno M; Ashikaga T; Antunes MA; Rocco PRM; Liu KD; Lee JW; Matthay MA; McKenna DH; Weiss DJ
Am J Physiol Lung Cell Mol Physiol; 2019 Dec; 317(6):L823-L831. PubMed ID: 31553626
[TBL] [Abstract][Full Text] [Related]
15. Inhaled Placental Mesenchymal Stromal Cell Secretome from Two- and Three-Dimensional Cell Cultures Promotes Survival and Regeneration in Acute Lung Injury Model in Mice.
Kudinov VA; Artyushev RI; Zurina IM; Zorina ES; Lapshin RD; Snopova LB; Mukhina IV; Saburina IN
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408778
[TBL] [Abstract][Full Text] [Related]
16. Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment.
Aghayan HR; Salimian F; Abedini A; Fattah Ghazi S; Yunesian M; Alavi-Moghadam S; Makarem J; Majidzadeh-A K; Hatamkhani A; Moghri M; Danesh A; Haddad-Marandi MR; Sanati H; Abbasvandi F; Arjmand B; Azimi P; Ghavamzadeh A; Sarrami-Forooshani R
Stem Cell Res Ther; 2022 Jul; 13(1):365. PubMed ID: 35902979
[TBL] [Abstract][Full Text] [Related]
17. Role of genetically engineered mesenchymal stem cell exosomes and LncRNAs in respiratory diseases treatment.
Jasim SA; Aziz DZ; Mustafa YF; Margiana R; Al-Alwany AA; Hjazi A; Alawadi A; Yumashev A; Alsalamy A; Fenjan MN
Pathol Res Pract; 2024 Feb; 254():155135. PubMed ID: 38295461
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of products derived from mesenchymal stem/stromal cells in pulmonary disease.
Mohammadipoor A; Antebi B; Batchinsky AI; Cancio LC
Respir Res; 2018 Nov; 19(1):218. PubMed ID: 30413158
[TBL] [Abstract][Full Text] [Related]
19. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Severe COVID-19.
Xiong J; Chen L; Zhang L; Bao L; Shi Y
Cell Transplant; 2021; 30():963689721995455. PubMed ID: 33650894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
